Navigation Links
Clinical ovarian cancers display extensive genetic heterogeneity, study suggests multiple treatment
Date:11/14/2013

independent TP53 driver mutations, each of which was present in only subsets of the ovarian tumor samples. This level of heterogeneity was also manifested in different evolutionary pathways that each instance of cancer took, with some cancers following a linear progression while the TP53 instance displayed early branching, in which each branch has its own genetic set of mutations.

"Ovarian cancers are typically diagnosed when the disease is at an advanced stage and the tumor mass is often large with numerous metastases throughout the abdominal cavity," said Wigard P. Kloosterman, a principal investigator at the University Medical Center Utrecht and lead author of the study. "Following primary debulking surgery, we obtained a large number of samples from each of these women, which enabled the study of intra-tumor heterogeneity before chemotherapeutic or other drug treatments were applied. The current study, representing the most comprehensive data set to date, reveals extensive heterogeneity, which is probably one of the reasons this disease is so difficult to treat."

The study did reveal marked gene expression differences between tumor biopsies from the same patient. These include altered expression of WNT, integrin and Hedgehog pathway members in subsets of tumor biopsies. Currently, targeted therapies for ovarian cancer patients are being developed and proper patient stratification is essential for successful treatment. For example, application of Hedgehog pathway inhibitors is an emerging strategy that could only prove useful in those patients displaying changes in Hedgehog signaling. The results from this study suggest that fine-tuning of patient stratification for targeted therapy would require analysis of multiple biopsies per patient.

"This study is a key first step in the community's effort towards personalized medicine, one in which we characterize the mutational landscape within an individual's cancer," said Timothy Harkins, a Dir
'/>"/>

Contact: Suzanne Clancy
Suzanne.Clancy@lifetech.com
760-602-4545
Life Technologies
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Elseviers Biochimica et Biophysica Acta (BBA) journal series adds open access journal: BBA Clinical
2. Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A
3. Development and clinical approval of biodegradeble magnesium alloy
4. Use of Biomarkers in Clinical Trials for Drugs Outside of Oncology is Increasing
5. KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH
6. Breastfeeding as a possible deterrent to autism -- a clinical perspective
7. Projecis Cloud-based Collaboration Platform Selected by Spaulding Clinical to Manage Phase I Clinical Trial Projects and Timelines
8. Arcturus Therapeutics Raises $5 Million in Series A Funding to Maintain its Momentum in Nominating Lead Clinical Candidate in 2014
9. Picofemto Deploys Cloud-Based Cliniscan EEG Analytics and Clinical Decision Support
10. UNLV, Sen. Reid Announce $20 Million NIH grant to support clinical health research
11. Wistar receives $1.5 million Department of Defense grant to ready prostate drug for clinical use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... essentially the same DNA sequence their genetic information. ... cells in the different parts of the body are ... construction master plan, an additional regulatory layer exists that ... active. This mechanism involves modifications of genome-bound histone proteins ... methylation). It acts on top of the genetic information ...
(Date:9/2/2014)... ideal source of nutrition for infants and it ... evolution and civilizations of human beings. Unlike our ... of bacterial species, including some opportunistic pathogens of ... scientists and physicians. , Indeed, the existence of ... of co-evolutionary and co-adaptive interactions between the microbiome ...
(Date:9/2/2014)... also known as perching birds, that migrate by night ... in autumn to reach their destinations. This seasonal difference ... only make short migratory flights, says researcher Cecilia Nilsson ... Behavioral Ecology and Sociobiology . , Nilsson, in ... tracking radar to measure over three years the speed ...
Breaking Biology News(10 mins):Throwing a loop to silence gene expression 2Are human breast milk microbiome 'neutral'? 2Are human breast milk microbiome 'neutral'? 3Migrating birds sprint in spring, but take things easy in autumn 2
... sounds like hype from a late-night infomercial: It can ... It could someday help you fend off disease! ... from several institutions including the U.S. Department of Energy,s ... of the cell,s protein-making machine, the ribosome, at key ...
... A G8 report released today in Paris indicating an ... by the Partnership for Maternal, Newborn and Child Health (PMNCH). ... for Maternal, Newborn and Child Health, with an initial commitment ... today suggests that collectively the G8 will surpass this initial ...
... encourage dedication to science, originality and excellence by rewarding ... Prize in the Physical Sciences was awarded to Prof. ... pioneering new fields and developing research tools for the ... Scholes of Toronto University for his work in the ...
Cached Biology News:Atomic-scale structures of ribosome could help improve antibiotics 2Atomic-scale structures of ribosome could help improve antibiotics 3A G8 report released today in Paris indicating an increase in financing for women's and children's health 2Tel Aviv University's Sackler Prizes awarded to 2 North American chemists 2
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... $2.1 million. The orders consist of three large odour control ... . "These orders are consistent with the ... Peter Bruijns , President and CEO. "After a difficult ... we are now beginning to see sales growth. Our lower ...
(Date:9/2/2014)... , September 2, 2014 ... BioData,s research and lab management services  BioData, ... service, is pleased to announce the appointment of ... most recently served as VP Marketing and Business Development ... science research and clinical applications. Previously, Culot ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 The ... $1,712.1 million by 2019 from $1,070.7 million in ... 2014 to 2019. The global oligonucleotide synthesis market ... services, applications, end users, and geography. The synthesized ... growth rate in the oligonucleotide synthesis market during ...
(Date:8/31/2014)... 01, 2014 Available spectra is ... for research and cultivation of a wide range ... proprietary LEDs with proven patented and pending wide ... light uniformity in critical applications in contrast to ... , “Our customers have a large variety of ...
Breaking Biology Technology:Louis Culot Appointed as BioData's CEO 29.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 29.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 39.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 49.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 5
... of business, the online reality is that many Internet users ... ,Many Internet surfers often believe they know a good Web ... a number of surface-level factors. For example, surfers are more ... natural results of a search engine query than when it ...
... The next time you use the Web or ... you might be getting the data from a company in ... data to a range of other map and travel services, ... meet with the demand from its contracts with Yahoo and ...
... Desktop search applications bring some of the same technology used ... market is getting more crowded. , ,The University of Wisconsin-Madison ... for usability, accuracy, versatility, efficiency, security and enterprise readiness in ... came out the overall winner, ceding ground only in ...
Cached Biology Technology:Many still distrust Web sites is yours credible enough? 2Many still distrust Web sites is yours credible enough? 3Madison-based TrafficCast makes national inroads as data provider 2Madison-based TrafficCast makes national inroads as data provider 3
Anti-human Carcinoma Associated Antigen, Clone 115D8, Monoclonal Antibody Innate Immunity - Tumor Markers...
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Anti-Mouse C-10, Biotin (Polyclonal) (rabbit IgG)...
Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
Biology Products: